Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: Impact on bone and mineral metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1246-1254

  Baek, Ki Hyun ^a   Lee, Won Young ^b   Oh, Ki Won ^c   Kim, Hye Soo ^a   Han, Je Ho ^a   Kang, Moo Il ^a,d   Cha, Bong Yun ^a   Lee, Kwang Woo ^a   Son, Ho Young ^a   Kang, Sung Koo ^a   Kim, Choon Choo ^a  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c MizMedi Hospital   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLONY STIMULATING FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; OSTEOCALCIN; OSTEOPROTEGERIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FOLLOW UP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MINERAL METABOLISM; OSSIFICATION; OSTEOLYSIS; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE REMODELING; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 12144291073     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031206     Document Type: Article

References (36)

1. Castaneda S, Carmona L, Carvajal I, Arranz R, Diaz A, Garcia-Vadillo A 1997 Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 60:343-347
2. Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T 1999 A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 23:355-361
3. Kang MI, Lee WY, Oh KW, Han JH, Song KH, Cha BY, Lee KW, Son HY, Kang SK, Kim CC 2000 The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 26:275-279
4. Schulte C, Beelen DW, Schaefer UW, Mann K 2000 Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 11:344-353
5. Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP 1999 Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation. J Bone Miner Res 14:342-350
6. Weilbaecher KN 2000 Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 6:165-174
7. Lee WY, Cho SW, Oh ES, Oh KW, Lee JM, Yoon KH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC 2002 The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 87:329-335
8. Buchs N, Helg C, Collao C, Chapuis B, Slosman D, Bonjour JP, Rizzoli R 2001 Allogenic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int 12:880-886
9. Carlson K, Simonsson B, Ljunghall S 1994 Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 55:408-411
10. Lee WY, Kang MI, Oh ES, Oh KW, Han JH, Cha BY, Lee KW, Son HY, Kang SK, Kim CC 2002 The role of cytokines in the changes of bone turnover following bone marrow transplantation. Osteoporosis Int 13:62-68
11. Canalis E 2001 Skeletal growth factors. In: Marcus R, Feldman D, Kelsey J. Osteoporosis. 2nd ed. San Diego: Academic Press; 405-431
12. Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth factors and bone: the osteoporosis connection. Exp Biol Med. 206:83-102
13. Rosen CJ 1999 Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 45:1384-1390
14. Fujikawa Y, Sabokbar A, Neale SD, Itonaga I, Torisu T, Athanasou NA 2001 The effect of macrophage-colony stimulating factor and other humoral factors on human osteoclast formation from circulating cells. Bone 28:261-267
15. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
16. Aubia J, Masramon J, Serrano S, Lioveras J, Marinoso LL 1988 Bone histology in renal transplant patients receiving cyclosporin. Lancet 1:1048-1049
17. Canalis, E 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
18. Reid IR, Chapman GE, Fraser TRC 1986 Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab 62:379-383
19. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD 1987 Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 2:559-565
20. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR 1986 Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516-518
21. Ferra C, de Sanjose S, Gallardo D, Berlanga JJ, Rueda F, Marin D, de la Banda E, Ancin I, Peris J, Garcia J, Granena A 1998 IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation. Haematologica 83:1082-1087
22. Min CK, Lee WY, Min DJ, Lee DG, Kim YJ, Park YH, Kim HJ, Lee S, Kim DW, Lee JW, Min WS, Kim CC 2001 The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 28:935-940
23. Banfi A, Podestá M, Fazzuoli L, Sertoli MR, Venturini M, Santini G, Cancedda R, Quarto R 2001 High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors. Cancer 92:2419-2428
24. Couto-silva AC, Trivin C, Esperou H, Michon J, Fischer A, Braumer R 2000 Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant 26:1205-1210
25. Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee L-J, Tanaka H, Seino Y 1995 The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy. J Bone Miner Res 10:1853-1864
26. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K 1997 Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279
27. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58.
28. Stanley ER, Heard PM 1977 Factors regulating macrophage production and growth: purification and some properties of the colony-stimulating factor from medium conditioned by mouse L cells. J Biol Chem 252:4305-4312
29. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
30. Fahrleitner A, Prenner G, Leb G, Tscheliessnigg KH, Piswanger-Solkner C, Obermayer-Pietsch B, Portugaller HR, Berghold A, Dobnig H 2003 Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone 32:96-106
31. Sato T, Tominaga Y, Iwasaki Y, Kazama JJ, Shigematsu T, Inagaki H, Watanabe I, Katayama A, Haba T, Uchida K, Fukagawa M 2001 Osteoprotegerin levels before and after renal transplantation. Am J Kidney Dis 38:S175-S177
32. Sasaki N, Kusano E, Ando Y, Yano K, Tsuda E, Asano Y 2001 Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. Nephrol Dial Transplant 16:479-482
33. Hofbauer LC, Shui C, Riggs BL, Dunstan CR, Spelsberg TC, O'Brien T, Khosla S 2001 Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 280:334-339
34. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanismby which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337
35. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR 1994 Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016
36. Okunieff P, Barrett AJ, Phang SE, Li A, Constine LS, Williams JP, Rubin P, Wang X, Wu T, Chen Y, Ding I 1999 Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation Bone Marrow Transplant 23:1117-1121